From conversion to aggregation: protofibril formation of the prion protein ML DeMarco, V Daggett Proceedings of the National Academy of Sciences 101 (8), 2293-2298, 2004 | 395 | 2004 |
Unifying features in protein-folding mechanisms S Gianni, NR Guydosh, F Khan, TD Caldas, U Mayor, GWN White, ... Proceedings of the National Academy of Sciences 100 (23), 13286-13291, 2003 | 321 | 2003 |
The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: a systematic … LM Forgrave, M Ma, JR Best, ML DeMarco Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11, 730-743, 2019 | 175 | 2019 |
Structural glycobiology: a game of snakes and ladders ML DeMarco, RJ Woods Glycobiology 18 (6), 426-440, 2008 | 170 | 2008 |
Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease RS Armen, ML DeMarco, DOV Alonso, V Daggett Proceedings of the National Academy of Sciences 101 (32), 11622-11627, 2004 | 169 | 2004 |
Extension of the GLYCAM06 biomolecular force field to lipids, lipid bilayers and glycolipids MB Tessier, ML DeMarco, AB Yongye, RJ Woods Molecular Simulation 34 (4), 349-364, 2008 | 109 | 2008 |
Molecular mechanism for low pH triggered misfolding of the human prion protein ML DeMarco, V Daggett Biochemistry 46 (11), 3045-3054, 2007 | 108 | 2007 |
Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases A Chang, X Xiang, J Wang, C Lee, T Arakhamia, M Simjanoska, C Wang, ... Cell 185 (8), 1346-1355. e15, 2022 | 107 | 2022 |
Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults MA Brockman, F Mwimanzi, HR Lapointe, Y Sang, O Agafitei, PK Cheung, ... The Journal of infectious diseases 225 (7), 1129-1140, 2022 | 107 | 2022 |
Preventing misfolding of the prion protein by trimethylamine N-oxide BJ Bennion, ML DeMarco, V Daggett Biochemistry 43 (41), 12955-12963, 2004 | 100 | 2004 |
Diafiltration MALDI-TOF mass spectrometry method for culture-independent detection and identification of pathogens directly from urine specimens ML DeMarco, CAD Burnham American Journal of Clinical Pathology 141 (2), 204-212, 2014 | 95 | 2014 |
Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models ML DeMarco, J Silveira, B Caughey, V Daggett Biochemistry 45 (51), 15573-15582, 2006 | 95 | 2006 |
Atomic-resolution conformational analysis of the GM3 ganglioside in a lipid bilayer and its implications for ganglioside–protein recognition at membrane surfaces ML DeMarco, RJ Woods Glycobiology 19 (4), 344-355, 2009 | 86 | 2009 |
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy ZL Brumme, F Mwimanzi, HR Lapointe, PK Cheung, Y Sang, MC Duncan, ... npj Vaccines 7 (1), 28, 2022 | 84 | 2022 |
Biomarker development for chronic obstructive pulmonary disease. From discovery to clinical implementation DD Sin, Z Hollander, ML DeMarco, BM McManus, RT Ng American journal of respiratory and critical care medicine 192 (10), 1162-1170, 2015 | 75 | 2015 |
Local environmental effects on the structure of the prion protein ML DeMarco, V Daggett Comptes rendus biologies 328 (10-11), 847-862, 2005 | 69 | 2005 |
Beyond identification: emerging and future uses for MALDI-TOF mass spectrometry in the clinical microbiology laboratory ML DeMarco, BA Ford Clinics in laboratory medicine 33 (3), 611-628, 2013 | 68 | 2013 |
Presentation of membrane-anchored glycosphingolipids determined from molecular dynamics simulations and NMR paramagnetic relaxation rate enhancement ML DeMarco, RJ Woods, JH Prestegard, F Tian Journal of the American Chemical Society 132 (4), 1334-1338, 2010 | 63 | 2010 |
Biomarker development in COPD: moving from P values to products to impact patient care Z Hollander, ML DeMarco, M Sadatsafavi, BM McManus, RT Ng, DD Sin Chest 151 (2), 455-467, 2017 | 59 | 2017 |
From agonist to antagonist: structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins ML DeMarco, RJ Woods Molecular immunology 49 (1-2), 124-133, 2011 | 49 | 2011 |